# FDA Inspection 1121335 - WuXi Advanced Therapies - January 22, 2020

Source: https://www.globalkeysolutions.net/records/fda_inspections/wuxi-advanced-therapies/0a449cf5-20ff-4805-b457-1937e3622faa
Source feed: FDA_Inspections

> FDA Inspection 1121335 for WuXi Advanced Therapies on January 22, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1121335
- Company Name: WuXi Advanced Therapies
- Inspection Date: 2020-01-22
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1299454 - 2025-11-25](https://www.globalkeysolutions.net/records/fda_inspections/wuxi-advanced-therapies/3ea12386-b657-449c-b644-e365d8fe3cee)
- [FDA Inspection 1299454 - 2025-11-25](https://www.globalkeysolutions.net/records/fda_inspections/wuxi-advanced-therapies/1f18cb39-7ccf-4206-9dc5-548c27bdc8b5)
- [FDA Inspection 1262215 - 2025-02-07](https://www.globalkeysolutions.net/records/fda_inspections/wuxi-advanced-therapies/b2abda4e-18e9-4bae-bfb9-d3361e7d2540)
- [FDA Inspection 1262215 - 2025-02-07](https://www.globalkeysolutions.net/records/fda_inspections/wuxi-advanced-therapies/b947c96b-65c6-4ce5-b651-258f5e4a8432)
- [FDA Inspection 921995 - 2015-04-17](https://www.globalkeysolutions.net/records/fda_inspections/wuxi-advanced-therapies/c0b6184b-9c4a-43f0-b96a-8c40e321304f)

Company: https://www.globalkeysolutions.net/companies/wuxi-advanced-therapies/2d12016c-2b9d-4b5e-91a8-4f8af5bee2e1

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c